West Pharmaceutical Services, Inc. (WST)
NYSE: WST · Real-Time Price · USD
298.64
+6.51 (2.23%)
Apr 29, 2026, 10:15 AM EDT - Market open
WST Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 3,221 | 3,074 | 2,893 | 2,950 | 2,887 | 2,832 | Upgrade
|
| Revenue Growth (YoY) | 11.23% | 6.25% | -1.92% | 2.18% | 1.95% | 31.89% | Upgrade
|
| Cost of Revenue | 2,053 | 1,970 | 1,895 | 1,820 | 1,751 | 1,654 | Upgrade
|
| Gross Profit | 1,169 | 1,104 | 998.5 | 1,130 | 1,136 | 1,178 | Upgrade
|
| Selling, General & Admin | 402.6 | 389.7 | 334.9 | 354.1 | 316 | 356.3 | Upgrade
|
| Research & Development | 73.8 | 74.3 | 69.1 | 68.4 | 58.5 | 52.8 | Upgrade
|
| Other Operating Expenses | -1.2 | 1.3 | 0.9 | 1.3 | -2.1 | - | Upgrade
|
| Operating Expenses | 475.2 | 465.3 | 404.9 | 423.8 | 372.4 | 409.1 | Upgrade
|
| Operating Income | 693.3 | 638.7 | 593.6 | 706.2 | 763.8 | 768.6 | Upgrade
|
| Interest Expense | -2 | -0.5 | -3 | -9 | -7.9 | -8.2 | Upgrade
|
| Interest & Investment Income | 18.5 | 17.5 | 19.6 | 28 | 5.1 | 1 | Upgrade
|
| Earnings From Equity Investments | 14.4 | 14.4 | 14.7 | 17.7 | 20.7 | 20.1 | Upgrade
|
| Currency Exchange Gain (Loss) | -8.3 | -8.4 | -10.2 | -9.4 | 4.1 | 1.4 | Upgrade
|
| EBT Excluding Unusual Items | 715.9 | 661.7 | 614.7 | 733.5 | 785.8 | 782.9 | Upgrade
|
| Merger & Restructuring Charges | -13.5 | -29.5 | -2.1 | 2 | -23.8 | -2.2 | Upgrade
|
| Gain (Loss) on Sale of Investments | -4.5 | -4.5 | -0.3 | -4.3 | -3.5 | -4.3 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | - | -11.6 | - | - | Upgrade
|
| Asset Writedown | -3.7 | -3.7 | -7 | -5.3 | -2.7 | -4.1 | Upgrade
|
| Legal Settlements | - | - | - | 3.8 | - | - | Upgrade
|
| Other Unusual Items | -9.3 | -8.7 | -5.1 | -2.4 | -55.2 | -3.3 | Upgrade
|
| Pretax Income | 684.9 | 615.3 | 600.2 | 715.7 | 700.6 | 769 | Upgrade
|
| Income Tax Expense | 142.2 | 121.6 | 107.5 | 122.3 | 114.7 | 107.2 | Upgrade
|
| Net Income | 542.7 | 493.7 | 492.7 | 593.4 | 585.9 | 661.8 | Upgrade
|
| Net Income to Common | 542.7 | 493.7 | 492.7 | 593.4 | 585.9 | 661.8 | Upgrade
|
| Net Income Growth | 16.16% | 0.20% | -16.97% | 1.28% | -11.47% | 91.16% | Upgrade
|
| Shares Outstanding (Basic) | 72 | 72 | 73 | 74 | 74 | 74 | Upgrade
|
| Shares Outstanding (Diluted) | 73 | 73 | 74 | 75 | 76 | 76 | Upgrade
|
| Shares Change (YoY) | -1.12% | -1.36% | -2.13% | -0.66% | -0.66% | 0.66% | Upgrade
|
| EPS (Basic) | 7.52 | 6.83 | 6.75 | 7.99 | 7.88 | 8.90 | Upgrade
|
| EPS (Diluted) | 7.48 | 6.79 | 6.69 | 7.88 | 7.73 | 8.67 | Upgrade
|
| EPS Growth | 17.39% | 1.49% | -15.10% | 1.94% | -10.84% | 89.72% | Upgrade
|
| Free Cash Flow | 458 | 468.9 | 276.4 | 414.5 | 439.4 | 330.6 | Upgrade
|
| Free Cash Flow Per Share | 6.31 | 6.45 | 3.75 | 5.50 | 5.80 | 4.33 | Upgrade
|
| Dividend Per Share | 0.860 | 0.850 | 0.810 | 0.770 | 0.730 | 0.690 | Upgrade
|
| Dividend Growth | 4.88% | 4.94% | 5.20% | 5.48% | 5.80% | 6.15% | Upgrade
|
| Gross Margin | 36.28% | 35.91% | 34.51% | 38.31% | 39.36% | 41.59% | Upgrade
|
| Operating Margin | 21.52% | 20.78% | 20.52% | 23.94% | 26.46% | 27.14% | Upgrade
|
| Profit Margin | 16.85% | 16.06% | 17.03% | 20.12% | 20.29% | 23.37% | Upgrade
|
| Free Cash Flow Margin | 14.22% | 15.25% | 9.55% | 14.05% | 15.22% | 11.68% | Upgrade
|
| EBITDA | 869.9 | 810.1 | 749 | 843.5 | 884.4 | 890.9 | Upgrade
|
| EBITDA Margin | 27.01% | 26.35% | 25.89% | 28.59% | 30.64% | 31.46% | Upgrade
|
| D&A For EBITDA | 176.6 | 171.4 | 155.4 | 137.3 | 120.6 | 122.3 | Upgrade
|
| EBIT | 693.3 | 638.7 | 593.6 | 706.2 | 763.8 | 768.6 | Upgrade
|
| EBIT Margin | 21.52% | 20.78% | 20.52% | 23.94% | 26.46% | 27.14% | Upgrade
|
| Effective Tax Rate | 20.76% | 19.76% | 17.91% | 17.09% | 16.37% | 13.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.